TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $11,171,000 | -8.5% | 618,556 | -2.4% | 0.49% | -6.6% |
| Q1 2015 | $12,204,000 | +6.5% | 633,972 | -3.2% | 0.53% | +4.3% |
| Q4 2014 | $11,464,000 | +14.2% | 654,687 | +19.2% | 0.51% | +17.9% |
| Q3 2014 | $10,037,000 | -19.1% | 549,380 | +2.0% | 0.43% | -8.7% |
| Q2 2014 | $12,409,000 | +18.5% | 538,835 | +24.7% | 0.47% | +24.7% |
| Q1 2014 | $10,470,000 | – | 432,100 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 815,041 | $15,690,000 | 4.96% |
| Lyon Street Capital, LLC | 570,387 | $10,980,000 | 4.73% |
| Centaur Capital | 135,000 | $2,599,000 | 3.61% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,690 | $5,962,000 | 3.48% |
| Paradice Investment Management LLC | 584,024 | $11,242,000 | 2.36% |
| RK Capital | 601,672 | $11,582,000 | 2.31% |
| Park West Asset Management LLC | 673,079 | $12,957,000 | 1.89% |
| KEANE CAPITAL MANAGEMENT INC | 95,259 | $1,834,000 | 1.79% |
| Adirondack Research & Management Inc. | 227,052 | $4,371,000 | 1.70% |
| Benchmark Capital Advisors | 92,441 | $1,779,000 | 1.17% |